Livzon Pharmaceutical Group (H) Aktie
Marktkapitalisierung
728,53 Mio. €
728,53 Mio. €
Streubesitz
31,59%
KGV
-
Dividende
0,14 €
Dividendenrendite
0,47%
Index-Zuordnung
-
Bilanz/GuV
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| EBITDA in Mio. | |||||
| EBITDA in Mio. | 2.633 € | 3.080 € | 3.325 € | 3.470 € | 3.493 € |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 973 € |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | - | 885 € |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | - | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | - | 379 € |
| Operatives Ergebnis (EBIT) in Mio. | |||||
| Operatives Ergebnis (EBIT) in Mio. | 2.188 € | 2.428 € | 2.485 € | 2.895 € | 2.919 € |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 973 € |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | 783 € | 885 € |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | 732 € | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | 529 € | 379 € |
| Finanzergebnis in Mio. | |||||
| Finanzergebnis in Mio. | 9.876 € | 10.395 € | 9.999 € | 8.982 € | 9.245 € |
| Ergebnis vor Steuern (EBT) in Mio. | |||||
| Ergebnis vor Steuern (EBT) in Mio. | 2.246 € | 2.331 € | 2.383 € | 2.806 € | 2.862 € |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 959 € |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | 764 € | 870 € |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | 694 € | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | 503 € | 366 € |
| Steuern auf Einkommen und Ertrag in Mio. | |||||
| Steuern auf Einkommen und Ertrag in Mio. | 294 € | 375 € | 485 € | 502 € | 451 € |
| Ergebnis nach Steuer in Mio. | |||||
| Ergebnis nach Steuer in Mio. | 1.776 € | 1.909 € | 1.954 € | 2.061 € | 2.023 € |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 637 € |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | 563 € | 644 € |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | 502 € | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | 388 € | 269 € |
| Nettogewinn/-verlust in Mio. | |||||
| Nettogewinn/-verlust in Mio. | - | - | - | - | - |
Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Umlaufvermögen in Mio. | |||||
| Umlaufvermögen in Mio. | 14.673 € | 16.987 € | 17.266 € | 16.420 € | 16.118 € |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 16.466 € |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | 17.507 € | 16.238 € |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | 16.613 € | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | 16.420 € | 16.118 € |
| Anlagevermögen in Mio. | |||||
| Anlagevermögen in Mio. | 7.699 € | 7.881 € | 7.779 € | 8.036 € | 7.867 € |
| Aktiva in Mio. | |||||
| Aktiva in Mio. | 22.372 € | 24.868 € | 25.045 € | 24.456 € | 23.985 € |
Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| kurzfristiges Fremdkapital in Mio. | |||||
| kurzfristiges Fremdkapital in Mio. | 6.925 € | 7.397 € | 8.087 € | 7.625 € | 7.220 € |
| langfristiges Fremdkapital in Mio. | |||||
| langfristiges Fremdkapital in Mio. | 1.136 € | 2.535 € | 2.191 € | 1.925 € | 1.219 € |
| Fremdkapital in Mio. | |||||
| Fremdkapital in Mio. | 8.061 € | 9.932 € | 10.278 € | 9.550 € | 8.438 € |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 9.110 € |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | 10.969 € | 9.249 € |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | 9.974 € | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | 9.550 € | 8.438 € |
| Minderheitenanteil in Mio. | |||||
| Minderheitenanteil in Mio. | 0 € | 1.060 € | 724 € | 1.043 € | 1.659 € |
| Eigenkapital in Mio. | |||||
| Eigenkapital in Mio. | 13.004 € | 13.876 € | 14.042 € | 13.862 € | 13.888 € |
| 1. Quartal | |||||
| 1. Quartal | - | - | - | - | 14.166 € |
| 2. Quartal | |||||
| 2. Quartal | - | - | - | 13.920 € | 13.678 € |
| 3. Quartal | |||||
| 3. Quartal | - | - | - | 14.159 € | - |
| 4. Quartal | |||||
| 4. Quartal | - | - | - | 13.862 € | 13.888 € |
| Passiva in Mio. | |||||
| Passiva in Mio. | 22.372 € | 24.868 € | 25.045 € | 24.456 € | 23.985 € |
Quelle: Leeway